Vertex Pharmaceuticals
AstraZeneca
Pfizer
BioNTech
Merck & Co.
Biogen
Regeneron Pharmaceuticals
Amgen
Gilead Sciences
AbbVie
Illumina, Inc.
Johnson & Johnson
Sanofi
GSK plc
Moderna is set to receive $176 million in federal funding to develop a human vaccine against bird flu following outbreaks of the virus in dairy cows across several states, the Department of ...
3 days ago
The Boston Globe
Moderna inks deal with US government to fund trial of bird flu vaccine - The Boston Globe
WFLA Tampa Bay
The US will pay Moderna $176 million to develop an mRNA pandemic flu vaccine
BBC News
US pays Moderna $176m to develop bird-flu vaccine
Forbes
Moderna Scores Federal Funding For mRNA Bird Flu Vaccine As Pandemic Fears Grow
4 days ago
Investor's Business Daily
Is Moderna Stock A Sell After Crumbling On Updated RSV Vaccine Results?
2 days ago
Reuters via Yahoo
Pfizer v Moderna COVID vaccine patents battle set to continue after UK ruling
TipRanks via Yahoo
Moderna Stock (NASDAQ:MRNA): Next-Gen COVID-19 Vaccine Is More Than a Rehash
Zacks via Yahoo
CHMP Endorses Moderna's (MRNA) mRNA-based RSV Vaccine
Barrons.com
Moderna Gets $176 Million From the U.S. to Make a Bird Flu Vaccine
View all
American biotechnology company
modernatx.com
Moderna, Inc. is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. Wikipedia
More on Yahoo Finance